That is a good question. In looking at the patent itself it appears that Crandell assigned to Xtreme Technologies in 2012 and then a security agreement was assigned back to Crandell in 2014. So there is probably some legitimate question to its ownership by Alkame. But I am not familiar with the content of the security agreement or what it might be used for or represents.
I did a little more looking. That security interest is likely Crandell being pledge the patent as collateral for a loan or something.
While the patent is assigned to and thus owned by Alkame, Crandell has a security interest in it.
Now that I think of it, this is one way Crandell can get the patent back if there is some sort of default on the agreement by Alkame.
Unfortunately it is a common practice in the OTC to allow an insider to get their asset back should the stock fail in any way...and not have to pay for it to do so.
The key would be to see the agreement...but I don't think it is available anywhere.
News 
Market Data 
Discover 
